Allogeneic adipose stem cell therapy in acute myocardial infarction

European Journal of Clinical Investigation

Volumn 44, Issue 1, 2014, Pages 83-92

  Rigol, Montserrat ^a   Solanes, Núria ^a   Roura, Santiago ^b   Roqué, Mercè ^a   Novensà, Laura ^a   Dantas, Ana Paula ^a   Martorell, Jaume ^c   Sitges, Marta ^a   Ramírez, José ^c   Bayés Genís, Antoni ^b   Heras, Magda ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Adipose tissue derived stem cells; Allogeneic stem cells; Experimental study; Myocardial infarction; Neovascularisation; Time of administration

Indexed keywords

ALLOANTIBODY; CD3 ANTIGEN; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY REPERFUSION; ENGRAFTMENT; FOLLOW UP; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; IMMUNE RESPONSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADIPOSE TISSUE-DERIVED STEM CELLS; ALLOGENEIC STEM CELLS; EXPERIMENTAL STUDY; MYOCARDIAL INFARCTION; NEOVASCULARISATION; TIME OF ADMINISTRATION;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; MYOCARDIAL INFARCTION; MYOFIBROBLASTS; STROKE VOLUME; SWINE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890679326     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12195     Document Type: Article

References (33)

1. Sans S, Puigdefabregas A, Paluzie G, Monterde D, Balaguer-Vintro I. Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia Study. Eur Heart J 2005;26:505-15.
2. Bai X, Alt E. Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun 2010;401:321-6.
3. Mazo M, Gavira JJ, Pelacho B, Prosper F. Adipose-derived stem cells for myocardial infarction. J Cardiovasc Trans Res 2011;4:145-53.
4. Bai X, Yan Y, Song Y, Seidensticker M, Rabinovich B, Metzele R et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010;31:489-501.
5. Bayes-Genis A, Soler-Botija C, Farré J, Sepúlveda P, Raya A, Roura S et al. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol 2010;49:771-80.
6. Rigol M, Solanes N, Farré J, Roura S, Roqué M, Berruezo A et al. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J Cardiac Fail 2010;16:357-66.
7. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1-7.
8. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P et al. Aging, progenitor cell exhaustion and atherosclerosis. Circulation 2003;108:457-63.
9. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20.
10. Poncelet AJ, Vercruysse J, Saliez A, Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007;83:783-90.
11. Poncelet AJ, Hiel AL, Vercruysse J, Hermans D, Zech F, Gianello P. Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model. Eur J Cardiothorac Surg 2010;38:781-7.
12. Huang XP, Sun Z, Miyagi Y, McDonald Kinkaid H, Zhang L, Weisel RD et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010;122:2419-29.
13. Horst KW. Stem cell therapy for myocardial infarction: are we missing time? Cardiology 2010;117:1-10.
14. Rigol M, Solanes N, Roqué M, Farré J, Batlle M, Roura S et al. Haemosiderin deposits confounds tracking of iron-oxide labelled stem cells. Transpl Proc 2008a;40:3619-22.
15. Solanes N, Rigol M, Khabiri E, Castellà M, Ramírez J, Roqué M et al. Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy. Cryobiology 2005;51:130-41.
16. Rigol M, Solanes N, Sionis A, Gálvez C, Martorell J, Rojo I et al. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response. J Heart Lung Transplant 2008b;27:416-22.
17. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg 1998;66:S212-5.
18. Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C et al. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res 2009;83:757-67.
19. Buja LM, Vela D. Immunologic and inflammatory reactions to exogenous stem cells. Implications for experimental studies and clinical trials for myocardial repair. J Am Coll Cardiol 2010;56:1693-700.
20. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008;29:251-9.
21. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X et al. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Res 2011;91:402-11.
22. Van den Borne SWM, Diez J, Balnkesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodelling after infarction: the role of myofibroblasts. Nat Rev Cardiol 2010;7:30-7.
23. Chintalgattu V, Harris GS, Akula Sm, Katwa LC. PPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc Res 2007;74:140-50.
24. Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L et al. Time curse of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005;100:217-23.
25. Hu X, Wang J, Chen J, Luo R, He A, Xie X et al. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardiothorac Surg 2007;31:438-43.
26. Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 2001;72:1957-63.
27. Sürder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S et al. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction. Circulation 2013;127:1968-79.
28. Bartunek J, Wijns W, Heyndrickx GR, Vanderheyden M. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3:S52-6.
29. O'Blenes SB, Li AW, Chen R, Arora RC, Horackova M. Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor. Ann Thorac Surg 2010;89:829-35.
30. Kupatt C, Hinkel R, Lamparter M, von Brühl ML, Pohl T, Horstkotte J et al. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs. Circulation 2005;112:I117-22.
31. Mazo M, Hernández S, Gavira JJ, Abizanda G, Araña M, López-Martínez T et al. Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction. Cell Transplant 2012;21:2723-33.
32. Ling L, Shen Y, Wang K, Jiang Ch, Fang Ch, Ferro A et al. Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One 2012;7:e50739.
33. Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S et al. Differential effects of progenitor cell population on left ventricular remodelling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 2010;55:2232-43.